Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 03 Mar 2026 for AbbVie Inc., €4.3M.
Filing timeline
BuySaleScott T. Reents
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Scott T. Reents: trading record in brief
Scott T. Reents is EVP, Chief Financial Officer of AbbVie Inc. The 25 filings in the record are published between February 21, 2023 and March 3, 2026, with 7 in 2023, 7 in 2024, 6 in 2025 and 5 in 2026. They are published a median of 5 days after the trade.
Four sales total EUR 8.1 million, with a median of EUR 2,250,771. The largest, EUR 3,451,226, is from March 14, 2025, ahead of February 23, 2024 (EUR 2,317,640) and March 1, 2023 (EUR 2,183,903). No purchase is in the record. The rest is made of 20 grants and 1 option exercise. Five filings fall in the last 12 months, with no sale.
Among AbbVie Inc. colleagues, Jeffrey Ryan Stewart, Perry C. Siatis and Timothy J. Richmond each traded within 30 days of 4 of Reents's trades, Azita Saleki-Gerhardt of 3 and Carrie C. Strom of 2, always in the same direction.
Companies and markets linked to Scott T. Reents
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
21,638 shares@ US$232.0834.0% of flowCommon Stock, $0.01 par valueSEC:0001937048-26-000004:0
8,910 shares0Common Stock, $0.01 par valueSEC:0001937048-26-000002:1
7,606 shares0Common Stock, $0.01 par valueSEC:0001937048-26-000002:2
7,260 shares0Common Stock, $0.01 par valueSEC:0001937048-26-000002:3
25,062 shares0Common Stock, $0.01 par valueSEC:0001937048-26-000002:0
17,644 shares@ US$212.3427.6% of flowCommon Stock, $0.01 par valueSEC:0001415889-25-008437:0
10,973 shares@ US$205.0217.3% of flowCommon Stock, $0.01 par valueSEC:0001415889-25-006584:0
5,845 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004458:0
2,398 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004458:1
8,912 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004458:2
7,608 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004458:3
14,140 shares@ US$177.4412.2% of flowCommon Stock, $0.01 par valueSEC:0001415889-24-006165:1
11,634 shares@ US$178.9910.1% of flowCommon Stock, $0.01 par valueSEC:0001415889-24-006165:2
14,140 shares@ US$61.366.4% of flowCommon Stock, $0.01 par valueSEC:0001415889-24-006165:0
11,800 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004419:0
3,146 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004419:1
2,398 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004419:2
8,912 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004419:3
15,092 shares@ US$153.0611.5% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-003854:1
850 shares@ US$153.380.6% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-003854:2
12,683 shares@ US$154.2814.7% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-003854:0
18,715 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002942:0
4,366 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002942:1
3,146 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002942:2
2,398 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002942:3
25 of 25 declarations
